Tuesday, July 10, 2018

Overview of Clinical Trials


           
           
           

Phase I: The experimental drug is tested in a small group of healthy individuals (20-80) to evaluate its safety, determine a safe dosage range, and identify side effects.

Phase II: The experimental drug is given to a group of patients with the disease being tested (100-300) to determine the drug effectiveness, dosage, and to further evaluate its safety by monitoring side effects.

Phase III: The experimental drug is given to a larger group of patients (1,000-3,000) to confirm its effectiveness, dosage, monitor side effects, and collect all relevant information to optimize therapeutic use.

Phase IV: Also called post-marketing study. The primary goal of phase IV trial is the long term assessment of the new drug safety and effectiveness.

Check “FREE Resources” at www.cpepreponline.com for more PEBC exams learning opportunities including free computer-based exam readiness tests.

No comments:

Free PEBC Exam Practice Questions

Helping You Prepare for Success! Find All Your Pharmacy Examining Board of Canada (PEBC) Exams EE, MCQ, OSCE, and OSPE Review Books, and Com...